Redmond, Wash.-based EchoNous received the investment from Kennedy Lewis Investment Management, with the funding combining senior secured debt and equity to build on the support of KKR, EchoNous’ principal investor since 2015, according to a news release.
The company said the proceeds will help propel the commercial launch of the Kosmos AI-guided point-of-care ultrasound system designed to provide diagnostic-quality imaging on par with larger, less portable and more expensive imaging machines.
Kosmos enables systolic heart function assessment, and EchoNous touts it as the only handheld point-of-care ultrasound system to offer continuous-wave Doppler capability. Additionally, the company said Kosmos is the only product of its size and category to meet HIPAA requirements for data collection, storage and transmission.
“This investment marks a turn toward an exciting future for POCUS in which clinical bedside medicine is driven by higher-performance ultrasound technologies that are easy to implement and cost-effective,” EchoNous CEO Kevin Goodwin said in the release. “To make this vision a reality, we value experienced partners who can see that future as clearly as we do. We could not be happier to have Kennedy Lewis’ support.”